1. Introduction
PR, also known as
Lamiophlomis rotata (Benth.) Kudô, is a medicinal herb called "Duyiwei" (
Lamiophlomis herba) in Chinese. It belongs to the
Phlomoides Moench of Lamiaceae and is found in high altitudes in China [
1,
2,
3,
4]. Traditionally, the root, rhizome, or the entire herb were used for medicinal purposes [
5,
6]. However, nowadays, only the aerial parts are used [
4], and the digging of the root is prohibited due to PR being listed as a first-class endangered Tibetan medicine [
6,
7]. The underground parts of PR are known for promoting blood circulation, eliminating stasis, reducing swelling, and providing analgesic effects. The above-ground parts are used for treating grasserie, fractures, injuries from falls, osteomyelitis, gunshot injuries, and edema pain [
2,
5,
6,
7].
Lamiophlomis herba is yellowish-brown or sallow, with a bitter and flat taste [
4,
5,
7]. It was first documented in the classical masterpiece of Tibetan Medicine, Somaratsa [
7], and has been used for more than 2000 years in traditional Tibetan medicine, known as "Daba" and "Dabuba," to treat traumatic injuries, rheumatic arthritis, and grasserie [
4,
5,
6,
7]. In clinical practice, PR is typically used directly without any prior processing, mainly for pain relief [
6]. Additionally, PR is commonly used as a key ingredient in combination with other Chinese herbs such as
Curcuma longa,
Salvia miltiorrhiza, and
Pyrrosia lingua [
6,
7]. PR is also utilized as an ingredient in various health products, including health drinks, soap, wine, mouth rinses, and biological toothpastes [
6].
Due to the low content of volatile chemicals, the focus on PR has primarily been on its involatile compounds. So far, at least 223 chemical constituents have been isolated and identified from PR, including iridoids, flavonoids, phenylethanoid glycosides, polysaccharides, organic acids, volatile oils, and others [
6,
7]. The main compounds found are iridoid glycosides, which are responsible for the analgesic effect [
6,
7] and serve as CMs to assess the quality of Duyiwei [
7]. However, apocarotenoids (also called norisoprenoids) [
8] have been largely overlooked. Previously, only two compounds of C13-norisoprenoids, 5
β, 6
α-dihydroxy-3
β-(
β-D-glucopyranosyloxy)-7-megastigmen-9-one [
6,
7,
9] and 3
β-hydroxy-5
α, 6
α-epoxy-7-megastigmen-9-one [
6,
10], and one compound of C18-norisoprenoids, hexahydrofarnesyl acetone, were reported [
11]. Additionally, sixteen organic acids, including PA, have been isolated and identified, seen in supplemental
Table S1 [
6,
7,
12,
13,
14]. As of now, only one study has reported the chemical composition in EOs extracted from PR using steam distillation, and another study has reported the lipophilic composition in the CH
2Cl
2 extracted part. Additional details and data can be found in supplemental
Table S2 [
11,
15]. The main compounds found in terms of content are FAs, especially LCFAs such as PA, MA, OA, and LA. However, some identifications are still debatable, such as OA, LA ethyl ester, and cyclohexenylacetic acid, taking into consideration the values of LRIs and the mass spectra [
11,
15]. Only three compounds, MA, PA, and LA, were detected in both studies [
11,
15]. Furthermore, some bound volatiles such as
α-terpineol-8-O-
β-D-glucopyranoside and (2Z)-2, 6-dimethyl-6-hydroxyocta-2, 7-dienyl-O-
β-D-glucopyranoside have been found [
7]. The identification of CMs in the EOs of PR is of great importance as these CMs play a crucial role in distinguishing these EOs from others rapidly [
16,
17,
18].
In recent years, there have been limited studies on the in-depth biological effects of volatile oils from PR [
7]. However, the petroleum ether extracted part has been reported to possess anti-tumor activities, suggesting that the volatile compounds may also have such activities [
19]. Currently, there have been no tests conducted on the AOAs of volatile chemicals extracted from PR. Oxidative stress has been associated with various diseases, including rheumatoid arthritis, cancer, and diabetes [
20,
21]. Additionally, supplemental FAs play an important role in maintaining the balance between oxidation and antioxidation in cells [
22,
23,
24,
25,
26,
27,
28,
29]. The effects of FAs on oxidant injury seem to be linked to the degree of unsaturation [
23]. PA, a type of SFAs, can increase oxidative stress in cells in a concentration-dependent manner [
28,
29]. This is because it can induce overexpression of the pro-oxidant protein p66Shc [
28] or react with cells to generate ROS, reduce the content of NO, and make cells more susceptible to oxidative stress [
29]. On the other hand, stearic acid, another type of SFAs, has been reported to protect pulmonary artery endothelial cells from oxidant injury [
23]. Generally, PUFAs can reduce oxidant injury [
24,
25,
26,
27], although contradictory results have also been reported [
23].
To the best of our knowledge, no single extract or compound from PR has been clinically applied for disease treatment thus far. Therefore, it is necessary to conduct studies and develop potentially therapeutic extracts or compounds [
7]. Building upon previous research [
30], our focus in this study is on the volatile chemicals and their AOAs. We have selected three samples of PR from Tibet to evaluate the CMs present in the EOs and their AOAs. The process involves isolating Crs from the EOs using cryoprecipitation, which resulting in CFs. Subsequently, a comprehensive chemical profiling study was conducted on the EOs, Crs, and CFs using GC-MS and GC-FID techniques. Meanwhile,
in vitro assays have been conducted to assess the AOAs of the EOs, Crs, CFs, and seven CMs, namely PA, MA, LA, OA, MP, PT, and DN. The findings of this study will establish a theoretical foundation for the utilization of EOs obtained from PR.
2. Results
2.1. Extraction and Separation
From PR with Voucher No. L8, L9, and L10, a total of 0.29 g, 0.26 g, and 0.19 g of light yellow EOs are obtained, corresponding to 418 μL, 405 μL, and 238 μL, respectively. The yields of EOs are calculated as 0.13%, 0.13%, and 0.08%, respectively, based on the ratio of the volume of the EOs (in mL) to the weight of the PR (in g) (mL/g). The densities of the EOs are measured as 0.69, 0.64, and 0.8, respectively. These EOs have a fresh and elegant smell. The Crs were separated from the EOs at temperatures of 4 °C or -4 °C, and the CFs were subsequently obtained by removing the Crs. Therefore, there are three sets of samples for L8, L9, and L10: EOs, Crs, and CFs. Specifically, there are nine samples: EO8, EO9, EO10, Cr8, Cr9, Cr10, CF8, CF9, and CF10.
2.2. Chemicals in the EOs of PR
A total of 121 compounds have been qualified and quantified. Among them, 31 have been reported previously [
11,
15], 4 should be introduced from outside sources, 2 are just identified as the two kinds of stereoisomer of
p-Menth-1-en-9-al, and 84 chemicals are reported for the first time from the EOs of PR, which is indicated in supplemental
Table S3 and
Figure 1.
The 121 compounds belong to various classes, mainly including FAs, EFAs, apocarotenoids which include C8N, C13N, and C18N, AMs, ADs, Als, OOMs, AAs, and Introduced. The relative contents of these classesobtained by MF are listed in
Figure 2.
Only eight compounds including hexanal, 1-octen-3-ol, limonene, linalool, α-terpineol, hexahydrofarnesyl acetone, MP, and PA were detected by MD. Among them, the contents of limonene, α-terpineol, and PA are relatively high.
The EOs, Crs, and CFs primarily consist of FAs, particularly LCFAs. PA stands out as the most prominent FAs, which aligns with the reported findings [
11,
15]. Additionally, MA, OA, and LA are also significant, as previously reported [
11,
15]. The content of PA is relatively higher in Crs but relatively lower in CFs compared to the corresponding EOs.
Regarding the EFAs, the major compounds are MP, methyl oleate, methyl linoleate, and methyl linolenate.
Apocarotenoids include one kind of C8N, eight types of C13N, and two kinds of C18N, in which, only hexahydrofarnesyl acetone was detected formerly [
11]. As for content, this compound also stands out. The content of C13N is relatively less, and its content in the EOs is relatively higher compared to that in the corresponding Crs or CFs. Among the AMs,
α-terpineol and linalool is relatively prominent. PT is a noteworthy ADs. Tricosane and pentacosane are two notable Als. In addition, compounds such as hexanal, 1-octen-3-ol, and
β-caryophyllene should also be observed. The four compounds such as limonene,
p-cymene,
γ-terpinene, and isoterpinolene, are likely introduced from the EOs extracted from the peels of Nanfengmiju (
Citrus kinokuni Hort. ex Tanaka), a variety of
C. reticulata, which were studied simultaneously [
16].
2.3. PCA and PLS-DA of the Samples and Metabolites
It is evident that within each group, the six samples are relatively closer to each other, while between the groups, they are relatively less close.
2.4. Analyses of Metabolic Pathways
As shown in
Figure 5, the main metabolic pathways are related FAs.
2.5. The Screening of CMs
After considering the screened 27 compounds, the compounds represented in the loadings of the PCA, the eight compounds identified by MD, and the relative content of each chemical, a total of 11 chemicals have been identified as the CMs: PA, DN, hexahydrofarnesyl acetone, MA, PT, stearic acid, linalool, hexanal, LA, OA, and MP.
2.6. AOAs of EOs, Crs, CFs, and Seven CMs of PA, DN, MA, PT, LA, OA, and MP
In the DPPH and ABTS assays, the IC
50 values of the samples were deduced from the results or undetected (
Supplemental Table S4).
In the DPPH assay (
Figure 6), among the nine samples of EOs, Crs, and CFs, CF10 exhibits the highest RSA as 29.81
±0.78% in the concentration of 110 μg·mL
-1. PA demonstrates POAs or weak AOAs at the concentrations as 100 μmol·L
-1. The RSA values of OA and LA show a positive correlation with their concentrations. At 2000 mmol·L
-1, the RSA value of LA is 63.18±0%, whereas that of OA is 28.79
±5.79%
The ABTS assay (
Figure 7) reveals that the RSA values of CFs are generally higher than those of the corresponding EOs or Crs, indicating that the Crs may contain compounds with POAs. The IC
50 value of QE is lower in the ABTS assay compared to the DPPH method.
In the FRAP assay, the AOAs are measured based on the concentration of Fe
2+ (mmol·L
-1). It is noteworthy that the FRAP values of nine samples of EOs, Crs, and CFs are similar to that of QE at 2.5 or 10 μmol·L
-1 (
Figure 8).
4. Materials and Methods
4.1. Plant Materials, Reagents and Chemicals
The aboveground portion of PR was collected from three populations: L8, L9, and L10. These populations corresponded to the same sample numbers used in a previous research study [
30]. The authenticity of the collected populations was confirmed by Professor Yi Zhang, from the Chengdu University of Traditional Chinese Medicine, Chengdu, China, and using ITS2 deoxyribonucleic acid barcodes, as described in the previous study [
30]. Voucher samples of L8, L9, and L10 were deposited in the College of Ethnic Medicine at Chengdu University of Traditional Chinese Medicine, Chengdu, China, and the Chongqing Academy of Chinese Materia Medica, Chongqing, China.
.
The following reagents and chemicals were used in this study: n-hexane (HPLC grade), linalool (98%+), p-cymene (99%+), α-terpineol (98%+), and nonane (98%), which were produced by Adamas Reagent Co., Ltd.; d-limonene (96%) produced by Acros Organics, the United States of America; γ-terpinene (97%) produced by Wako Pure Chemical Industries, Ltd., Japan; PA produced by CATO Research Chemicals Incorporated; n-Als standard solution of C10-C25 produced by Dr. Ehrenstorfer Incorporated, Germany; n-octacosane (99%) produced by Aldrich; DPPH, ABTS powder, potassium persulfate (K2S2O8), and Vc. All these reagents and chemicals were supplied by Shanghai Titan Scientific Co., Ltd., China. MeOH, used for preparative liquid phase, was sourced from Shanghai Lingfeng Chemical Reagent Co., Ltd. and supplied by Yonghua Chemical Co., Ltd.; MeOH (HPLC grade), produced by Adamas-beta, was supplied by Shanghai Titan Scientific Co., Ltd., China.
4.2. Extraction and Separation
Weighed powders of L8, L9, and L10 (315 g each) were placed in separate round-bottomed 5L flasks. Pure water (3150 mL, 10 Vs) was added to each flask. The mixtures were soaked for 0.5 hours at 40 °C. The EOs were extracted three times from each powder using hydrodistillation with a Clevenger-type apparatus. Each extraction lasted for 5 hours. n-Hexane was employed as the collecting solvent. The collected EOs, which appeared as light yellow, were treated with anhydrous Na2SO4 to eliminate any residual water.
To evaluate crystallization, the EOs of L8, L9, and L10 were stored at different temperatures: 4 °C, -4 °C, and -80 °C. Crs were obtained either at 4 °C or -4 °C. However, at -80 °C, the CFs of all three samples were in a solid state. Each sample was stored in separate screw-capped vials at 4 °C.
4.3. The Identification and Quantitation of Chemicals in the EOs, Crs, and CFs
4.3.1. Sample Preparation
The samples of EO8, EO9, EO10, Cr8, Cr9, Cr10, CF8, CF9, and CF10 were prepared for analyses according to the following procedure. For FD and MD, the samples were diluted in the ratio of Vsample: Vn-hexane (HPLC) 1:1000 (0.1%). For MF, the samples were diluted at a ratio of Vsample: Vn-hexane (HPLC) 1:250 (0.4%).
4.3.2. Chromatograms Obtained from GC Analyses
GC-FID analyses were conducted using a GC-2010 instrument from Shimadzu, Japan, equipped with a DB-5 column (30 m × 0.25 mm i.d., 0.25 μm film thickness). The following parameters were used: The oven temperature was programmed from 60 °C with a 3-minute hold, and then ramped up to 250 °C at a rate of 2.5 °C per minute. The final temperature was held for 2 minutes. Nitrogen was used as the carrier gas, with a constant flow rate of 1.7 mL per minute. Both the injector and the detector were maintained at 250 °C. The sample was split in a ratio of 5:1. Each sample was injected once with a V of 1 μL.
GC-MS analyses were performed using a GCMS-TQ8040 instrument from Shimadzu, Japan. Separately, either a DB-5 column or a FFAP column (30 m × 0.32 mm × 0.5 μm) was used. The following parameters were used.
For DB-5 column: The oven temperature was programmed from 60 °C with a 3-minute hold, and then ramped up to 280 °C at a rate of 2.5 °C per minute. The final temperature was held for 2 minutes. Helium was used as the carrier gas, with a constant flow rate of 1 mL per minute. The sample was split in a ratio of 100:1. A solvent delay of 3.0 minutes was implemented. The injector was maintained at 250 °C, while the ion-source and interface were maintained at 200 °C and 250 °C, respectively. Mass spectra were acquired at 70 eV with a scan rate of 3.9 scans per second, covering the mass range from m/z 25 to 450 amu. Each sample was injected once with a V of 1 μL.
For FFAP column: The oven temperature was programmed from 60 °C with a 3-minute hold, and then ramped up to 230 °C at a rate of 2.5 °C per minute. The final temperature was held for 2 minutes. The rest of the parameters (carrier gas, splitting ratio, solvent delay, injector, ion-source, interface temperature, mass spectra, injection times, and injection V) remained the same as for the DB-5 column.
4.3.3. Identification and Quantitation
The RT and area of each peak in the chromatograms were recorded. The mass spectrum of each peak was examined to identify and quantify the target compounds present in the TICs.
Identification
For compound identification, either a NIST 14 or a NIST 17 MS database was utilized. Initially, the peaks in the TICs were identified using probability-based matching. However, due to the presence of overlapped and embedded peaks in the TICs, the identification results may sometimes be inaccurate. In such cases, characteristic ion peaks were selected and compared with the NIST 14 or 17 database, as well as the mass spectra of known standards. By employing a combination of probability-based matching and comparing characteristic ion peaks, the compound identification process becomes more reliable, particularly when dealing with overlapping peaks. This approach enhances the overall accuracy and confidence in the identification results.
The LRIs values were calculated using the equation (1) proposed by Van Den Dool and Kratz [
61]. In equation (1), “t
n” and “t
n+1” represent the RT of the
n-Als (C
10-C
25, C
28, and the detected C
26-C
27, C
29) with the corresponding number (“n”) of carbons. "t
x" represents the RT of the detected compound x (t
x), where “t
n ≤ t
x ≤ t
n+1”. Furthermore, the RT of
n-Al C
30 (t
30) was deduced by analyzing the TICs obtained through MF.
The calculated LRIsb of FD and MD, and LRIsd of MF, were compared with the LRIa and LRIc values obtained by a semi-standard apolar column and a polar column from the NIST 17 library of the corresponding matched chemicals, respectively.
Quantification
For GC-MS detection, the overlapped peaks in the TICs were deconvoluted into individual peaks based on the characteristic ion peaks of the corresponding matching compound. In the case of GC-FID detection, the overlapped peaks were separated based on the peak shape and the corresponding results from GC-MS detection. The relative area percentage of each compound was calculated using peak area normalization.
4.4. PCA and PLS-DA
The data obtained from the TICs detected by MF and the chromatograms detected by FD were utilized to perform PCA and PLS-DA. The plots of VIP, PCA, and PLS-DA for the chemicals and nine samples detected by MF and FD were generated by R version 4.3.1. Chemicals with a VIP score ≥ 1.2 and a significance level of P ≤ 0.05 are considered significant.
4.5. Analyses of Metabolic Pathways
4.6. AOAs of EOs, Crs, CFs, and Seven CMs of PA, MA, OA, LA, MP, PT, and DN
The AOAs of nine samples, EO8, EO9, EO10, Cr8, Cr9, Cr10, CF8, CF9, and CF10, were tested by DPPH, ABTS, and FRAP assays, respectively.. Additionally, seven CMs including PA, MA, OA, LA, MP, PT, and DN, were included in the analyses. QE was used as a reference compound.
4.6.1. Sample Preparation
All the subjects were diluted in MeOH. Since there was a limited amount of volatile oils available, only three low concentrations, namely 50, 80, and 110 μg·mL-1, were set up for the nine samples. The two CMs including OA and LA were diluted to specific concentrations of 100, 200, 500, 1000, and 2000 mmol·L-1, respectively. The another two CMs including PT and DN were diluted to specific concentrations of 6.25, 12.5, 25, 50, and 100 mmol·L-1, respectively. The QE was diluted to 2.5, 5, 10, 20, and 50 μmol·L-1, respectively.
4.6.2. DPPH Assay
A slight modification was made to the experimental procedure [
62]. The samples, each with a V of 100 μL, at various concentrations were added to individual well of a 96-well microplate. Subsequently, 100 μL of DPPH solution (100 μmol·L
-1) also diluted with MeOH was added to each well. The microplate was then incubated in darkness at room temperature for 30 minutes. After the incubation period, the absorbance of the reaction mixture was measured at 517 nm using a microplate reader. Each sample was analyzed in triplicate, and MeOH was used as the blank control. The RSA was calculated using the following equation:
Where ABlank is the absorbance of the blank control (MeOH) and ASample is the absorbance of the reaction mixture. The RSA value indicates the percentage of DPPH radical scavenged by the sample, with higher values indicating stronger AOAs.
4.6.3. ABTS Assay
A slight modification was made to the method described in a previous study [
63]. To prepare the ABTS radical cation (ABTS
•+) solution, 5 mL of a 7 mM aqueous ABTS solution was reacted with 88 µL of a 140 mM K
2S
2O
8 aqueous solution (resulting in a final concentration of 2.45 mM for K
2S
2O
8). The reaction mixture was kept in darkness at room temperature for 16 hours. Subsequently, the radical cation solution was diluted with MeOH, typically around 30-50 times, until its absorbance reached a value of 0.7±0.02 at 734 nm. For each sample, 100 μL was added to 100 μL of the ABTS radical solution. The mixture was thoroughly mixed at room temperature for 6 minutes. Following the incubation period, the absorbance at 734 nm was measured using a microplate reader. The calculation method for RSA was consistent with that used in the DPPH assay.
4.6.4. FRAP Assay
A slight modification was made to the method described previously [
60]. For each sample, 100 μL was added to 100 μL of the FRAP working solution. The FRAP working solution was composed of acetic acid buffer (0.3 mol·L
-1), 2, 4, 6-Tris (2-pyridyl)-1, 3, 5-triazine solution (10 mM), and FeCl
3 (20 mM) solution, with a V ratio of 10:1:1. The sample and the FRAP working solution were thoroughly mixed and then placed in darkness at 37 °C for a 30-minute incubation period. After incubation, the absorbance of the mixture at 593 nm was immediately measured using a microplate reader. The increase in absorbance at this wavelength indicates the reduction capacity of the samples and provides information on their antioxidant potential.
To establish a calibration curve, 0.1 mL of Fe(II) aqueous solutions with concentrations ranging from 0.01 to 0.2 mM were mixed with 0.1 mL of the FRAP reagent. In this measuring system, the total antioxidant capacity was determined in terms of Fe(II) equivalents. The concentration of FeSO4 (in mmol·L-1) was calculated based on the absorbance value obtained from the standard curve after the reaction, which was referred to as the FRAP value. A higher FRAP value indicates a stronger AOA.
5. Conclusions
A comprehensive analysis of the EOs of PR has revealed a total of 121 identified and quantified compounds. Among them, 84 have been reported for the first time from the EOs of PR. In summary, a total of 11 compounds, including PA, MA, LA, OA, MP, hexahydrofarnesyl acetone, PT, DN, stearic acid, linalool, and hexanal, have been selected as the CMs. These CMs are biosynthesized through FAs and MEP/DoXP pathways.
Generally, CFs demonstrate stronger AOAs compared to EOs and Crs. This disparity is likely influenced by the varying content of PA in these samples. Specifically, the percentage of PA, the most abundant compound, is found to be higher in Crs but lower in CFs compared to EOs.
In future, it is important to exercise caution when treating plants, diluting samples, and setting the splitting ratio. Furthermore, we should investigate the synergistic effects of SFAs and MUFAs/PUFAs and focuse on samples that exhibit stronger AOAs, particularly.
This study significantly contributes to our understanding of the chemcials in the EOs of PR, shedding light on the potential application and utilization of such volatile oils.
Author Contributions
Conceptualization, Z.P. and J.W.; methodology, C.X. J.L., and J.W.; software, C.X., J.L., X.Y., and J.W.; validation, Z.P., C.X., J.L., X.Y., Y.S., and J.W.; investigation, C.X. and J.W.; resources, Z.P. and J.W.; data curation, C.X., J.L., X.Y. and J.W.; writing—original draft preparation, C.X., J.L., X.Y. and J.W.; writing—review and editing, Z.P., C.X., X.Y., Y.S., and J.W.; supervision, Z.P. and J.W.; project administration, Z.P. and J.W.; funding acquisition, Z.P. and J.W. All authors have read and agreed to the published version of the manuscript.
Figure 1.
The chromatograms of EO10, the EO extracted from L10. Each denoted compound is assigned the corresponding code as listed in
Supplementary Table S3.
Figure 1.
The chromatograms of EO10, the EO extracted from L10. Each denoted compound is assigned the corresponding code as listed in
Supplementary Table S3.
Figure 2.
The content of main categories obtained by MF.
Figure 2.
The content of main categories obtained by MF.
Figure 3.
A total of 27 compounds were screened based on a VIP value of not less than 1.2.
Figure 3.
A total of 27 compounds were screened based on a VIP value of not less than 1.2.
Figure 4.
The loadings of PCA (A) and PLS-DA plot of nine samples detected byFD and MF (B). The compounds represented in the loadings of PCA are as follows: AA2-Hexanol, AA3-Hexanol, C13N6-trans-Geranylacetone, EF1-Nonanoic acid, 9-oxo-, methyl ester, F9-PA, AM10-3,7-Octadiene-2,6-diol, 2,6-dimethyl-, O3-Hexanal, F5-Nonanoic acid, AS2-Cedrol, I2-Limonene, I1-p-Cymene, I3-γ-Terpinene. As for the sample name in the PLS-DA plot, the first character “E”, “F”, “C” refers to “EO”, “CF”, “Cr”, respectively; the middle number “8”, “9”, “10” refers to “L8”, “L9”, “L10”, respectively; the last character “D” and “F” refers to “FD” and “MF”, respectively.
Figure 4.
The loadings of PCA (A) and PLS-DA plot of nine samples detected byFD and MF (B). The compounds represented in the loadings of PCA are as follows: AA2-Hexanol, AA3-Hexanol, C13N6-trans-Geranylacetone, EF1-Nonanoic acid, 9-oxo-, methyl ester, F9-PA, AM10-3,7-Octadiene-2,6-diol, 2,6-dimethyl-, O3-Hexanal, F5-Nonanoic acid, AS2-Cedrol, I2-Limonene, I1-p-Cymene, I3-γ-Terpinene. As for the sample name in the PLS-DA plot, the first character “E”, “F”, “C” refers to “EO”, “CF”, “Cr”, respectively; the middle number “8”, “9”, “10” refers to “L8”, “L9”, “L10”, respectively; the last character “D” and “F” refers to “FD” and “MF”, respectively.
Figure 5.
The main metabolic pathways.
Figure 5.
The main metabolic pathways.
Figure 6.
The RSA values of nine samples of EOs, Crs, and CFs detected by DPPH.
Figure 6.
The RSA values of nine samples of EOs, Crs, and CFs detected by DPPH.
Figure 7.
The RSA values of nine samples of EOs, Crs, and CFs detected by ABTS assay.
Figure 7.
The RSA values of nine samples of EOs, Crs, and CFs detected by ABTS assay.
Figure 8.
The RSA values of nine samples of EOs, Crs, and CFs detected by FRAP assay.Overall, the AOAs of OA and LA are enhanced with the increase of concentration.
Figure 8.
The RSA values of nine samples of EOs, Crs, and CFs detected by FRAP assay.Overall, the AOAs of OA and LA are enhanced with the increase of concentration.
Figure 9.
The hypothetical transformation process from 5β, 6α-dihydroxy-3β-(β-D-glucopyranosyloxy)-7-megastigmen-9-one (1) to eight different types of C13N.
Figure 9.
The hypothetical transformation process from 5β, 6α-dihydroxy-3β-(β-D-glucopyranosyloxy)-7-megastigmen-9-one (1) to eight different types of C13N.
Figure 10.
The formation of apocarotenoids.
Figure 10.
The formation of apocarotenoids.
Figure 11.
The biosynthesis of CMs. Solid arrows represent established biosynthetic steps, whereas dashed line arrows indicate the transformation is hypothetical.
Figure 11.
The biosynthesis of CMs. Solid arrows represent established biosynthetic steps, whereas dashed line arrows indicate the transformation is hypothetical.
Table 1.
The origins of PR and the corresponding GenBank accession numbers of the ITS2 sequences, as mentioned in the previous study [
30].
Table 1.
The origins of PR and the corresponding GenBank accession numbers of the ITS2 sequences, as mentioned in the previous study [
30].
Voucher No. |
Sources |
GPS Coordinates |
GenBank Accession Number |
L8 |
BianBa, LeiWuQi and NaQu counties of Tibet |
E: 93° W: 31° |
KP699743/45-4750-51/54 |
L9 |
L10 |